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BACKGROUND: Hepatocellular cancer is the commonest liver 
cancer which contributes to a high incidence of morbidity and 
mortality in both developed and developing countries. Despite the 
anticipated high burden of the disease in the country, there is 
paucity of data on the associated risk factors and its pattern on 
imaging. The aim of this study was to assess Computed 
Tomography patterns and the risk factors of hepatocellular 
carcinoma. 
METHODS: A cross-sectional, prospective study on patients with a 
diagnosis of HCC on Computed Tomography examination, at 
Tikur Anbessa Specialized Hospital from July, 2016 to July, 2017. 
All patients who had characteristic Computed Tomography 
features and those who were diagnosed by Fine needle aspiration 
cytology (FNAC)/biopsy and had Computed Tomography 
examination were included in the study. Risk factors identified 
were reviewed from patients’ medical records. 
RESULT: A total of 70(n=70) patients were included in the study. 
The mean age was 50 ± 16 years. Fifty-seven (81.4%) of the 
participants were males, and 13(18.6%) were females.  Forty-five 
(64.3%) of them came from urban areas and 25(35.7%) of them 
were from rural areas. The lesions were focal in 52(74.3%) and 
infiltrative in 18(25.7%) of the cases. Vascular invasion and distant 
metastases were seen in 49(70%) and 17(24.3%) respectively. 
Twenty-nine (41%) had negative hepatitis markers, and 13(19%) 
were not investigated for hepatitis infection. 
CONCLUSION: The majority of the patients presented with 
advanced disease such as vascular invasion and metastases. The 
major risk factors such as hepatitis infection were negative in 
significant number of patients. The risk factors in our setting 
should be studied further. Moreover, high-risk group selection and 
screening is essential to diagnose HCC early.    
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Hepatocellular carcinoma (HCC) is the commonest form of liver 
cancer, and most frequently (approximately 80%), it is associated 
with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) 
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Infections (1). Other non-viral causes such as 
metabolic syndromes, aflatoxin exposure, alcohol use, 
tobacco use, and oral contraceptive use are also risk 
factors for HCC (2).  Most cases of HCC cases 
(>80%) occur in sub-Saharan Africa and in Eastern 
Asia, with a typical incidence rates of > 20 per 
100,000 individuals (1). 
There is no study on prevalence or incidence of 
hepatocellular cancer in Ethiopia. However, expected 
disease burden is significant because of high 
prevalence of hepatitis infection (approximately 
10%–15% of HBV and that of HCV is approximately 
2%–5 %) (3). 
By identifying the risk factors for HCC, high 
risk groups can be selected and enrolled in screening 
programs. In fact, the management of high-risk 
patients with screening and surveillance allows early 
detection of HCC and improve patient outcomes. 
When HCC is detected earlier, patients are candidates 
to receive curative treatments (4).  
Hepatic nodules can be diagnosed on 
Ultrasounds (US), including contrast-enhanced US 
(CEUS), or on other noninvasive techniques, such as 
contrast-enhanced computerized tomography (CT), 
magnetic resonance imaging (MRI) and positron 
emission tomography (PET)-CT. The typical feature 
of HCC on dynamic imaging is characterized by early 
arterial phase enhancement followed by loss of 
enhancement in the portal venous phase and delayed 
phase in comparison to the surrounding liver (5). In 
resource limited countries, patients come with 
advanced disease and there are only few treatment 
options for HCC. In our study, we assessed patterns 
of the disease on CT and if there were identifiable 




The study was conducted at Tikur Anbessa 
Specialized Hospital, Addis Ababa, Ethiopia. It is a 
tertiary hospital in the country where the only cancer 
center is located, and patients from all over the 
regions are referred to for better diagnostic and 
therapeutic services. The CT scanners were GE 
(General Electric) 64 slice and Philips 128 slice CT 
machines. The image quality acquired by the two CT 
scanners were comparable. Pre-contrast, arterial 
phase, portal venous phase and delayed phase images 
were taken consecutively. 
It is a cross-sectional prospective study which was 
carried out from July 2016 to July 2017 on 
consecutive patients who came for Computed 
Tomography examination to the Department of 
Radiology. Those who have CT characteristic feature 
of hepatocellular cancer or those who have CT with 
histopathology confirmation of hepatocellular cancer 
were included in the study. 
CT findings were reviewed and filled in 
structured questionnaire by the principal investigator. 
The diagnosis of hepatocellular carcinoma can be 
done non-invasively on the basis of typical imaging 
feature (6). A late arterial enhancement and venous or 
delayed phase washout in the background of cirrhosis 
or in patients with chronic hepatitis B infections was 
considered typical feature of HCC. All other clinical 
information including documented risk factors were 
reviewed from patients’ medical records. 
Statistical analysis: The statistical analysis was 
performed using the Statistical Package for Social 
Sciences (SPSS) for windows version 20. Mean was 
calculated for continuous variables. Frequencies were 
used to summarize categorical variables.  Fisher’s 
exact test was used to assess the significance of 
association between independent and dependent 
variables. The level of significance was considered as 
P < 0.05. 
Ethical consideration: Ethical approval to conduct 
the study was obtained from Ethics Review 
Committee of the Department of Radiology before 




A total of 70 (n=70) people were included in the 
study. Demographic characteristics of patients is 
shown in Table 1. The mean age was 50±16 years.  
Fifty-seven (81.4%) of the participants were males 
and 13(18.6%) were females.  Forty-five (64.3%) 
came from urban areas, and 25(35.7%) of them were 
from rural areas. 
 
Table.1: Socio-demographic characteristics of patients 
diagnosed with HCC at Tikur Anbessa specialized 
Hospital of year 2016-2017. 
Characteristics Number(Mean ± SD) 
Age 
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Table 2: CT imaging pattern of 70 patients with HCC at Tikur Anbessa specialized Hospital of the year 
2016-2017. APE=arterial phase enhancement, PVP=portal venous phase and DP=delayed phase 
 
Characteristics             Imaging pattern frequency (%)            
 Location  Right lobe 19(27%) Left lobe 9(13%) Both lobes 42(60 %) 
 Pre contrast density   
Enhancement pattern  
 Mass lesion 
Vascular invasion 
Biliary invasion                    
Metastasis 
Cirrhosis 
Hypodense 52(74 %) 
APE 70(100%)  
Focal 52(74.3%) 




Hyperdense 1(1.4 %) 
PVP washout 62(89%)                                





Heterogeneous 1(1.4%)  







Patterns depicted on CT are presented in Table 2.  
In 42(60%) of the patients, both hepatic lobes were 
involved by the tumor, while in 19(27%) and 
9(13%), it was localized to right lobe and left lobe 
respectively.  Fifty-two (74.3%) of the lesions were 
focal (Figure 1) while 18(23.7%) were infiltrative 
(Figure 2).  
Invasion of the vessels was demonstrated in 
48(69%) of them; from which the portal vein 
invasion contributed in 39(55.7%) of the cases 
(Figure 3) (Table 2). Biliary invasion was observed 
in 5(7.1%). 
Tumors’ density in the pre-contrast images 
was hypo in 52(74.3%), hyper and heterogeneous 
in 1(1.4%) cases each.  Pre-contrast image was not 
available in 16(22.9%) of the cases. Late arterial 
enhancement and venous phase washout are seen in 
62(88.6%) and late arterial enhancement and 
delayed phase washout in 8(11.4%). 
Liver cirrhosis was identified in 44(62.9%) 
and no CT evidence of cirrhosis in 26(37.1%) of 
the cases. Forty-four (62.9%) had ascites. 
Splenomegaly was seen in 20(28.6%). Fifteen 
(21.4%) had lymph node metastasis. No distant 
metastasis is seen in 53(75.7%) cases, and there 
was metastases to the lung and adrenal in 9(12.9%) 
and 4(5.7%) respectively. Other site metastasis was 
detected in 3(4.3%); 1(1.4%) of the cases had lung, 
adrenal and bone metastases. 
                                A                                                                        B 
Figure 1: CT images of a 72 year old male patient with hepatocellular cancer A; well defined heterogeneously hyper-
enhancing lesion with intratumoral neovascularization in arterial phase B; washout of the lesion in the portal venous 
phase 
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Figure 2: CT images of a 40 year old male patient 
with hepatocellular cancer A; An infiltrative and 
hyper-enhancing lesion on segment IVB of the liver 
on the arterial phase B. washout in the portal 
venous phase. C. Tumor thrombosis in the main 




Table 3 shows risk factors identified. Positive HBV 
and HCV test were revealed in 15(21.4%) and 
5(7.1%) respectively. Metabolic syndrome was a risk 
factor in 2(2.9%) and HIV in 1(1.4%). Other risk 
factors contributed to 4(5.7%) of the cases. In 
1(1.4%) of the cases, concomitant HBV, HIV, HBV 
and other risk factors were identified. Hepatitis B 
surface antigen (HBsAg) and Hepatitis C virus 
antibody (HCVab) results were negative in 29(41%) 
participants, and the tests were not performed in 
19.1% of the patients. Overall, the major risk factors 
were not identified in 41(58.6%) of the cases. HCC 
was confirmed by histopathology in 12(17.1%) of the 
patients. Infiltrative lesions were more associated 
with vascular invasion than focal lesions (P=0.005). 
 
Table 3: Pattern of risk factors identified in 70 HCC patients at Tikur Anbessa Hospital of year 2016-2017 
 
Risk factor identified Frequency  percent 
HBV 15 21.4 
HCV 5 7.1 
Metabolic syndrome 2 2.9 
HIV 1 1.4 
Unknown 41 58.6 
Others 4 5.7 
HBV and HIV 1 1.4 
HBV and other 1 1.4 
Total  70 100 
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The majority (81.4%) of the participants in our 
study were males, with male-to female-ratio of 4:1. 
Similarly, higher male-to-female ratio of 
hepatocellular cancer averaging between 2:1 and 
4:1 is reported in most population, and it is higher 
in high and medium incidence areas (7). Factors 
attributing to male predominance are hormonal 
effect (testosterone), the overall higher rate of 
cancer in male population, high exposure rate of 
HBV infection in males and others (7, 8). Mean 
age was 49.7 ±16 yrs. The most common affected 
age groups are age >65 yrs, which is 24.3% of the 
study subjects. This result has inconsistent pattern 
compared to a study done at Tikur Anbessa 
Hospital in which the age group of 55-64yrs 
accounted for 51% of the cases (9). We could not 
justify the difference between two results, and 
larger sample size study is suggested to understand 
overall demographic characteristics of HCC 
patients in the country (10).   
 In 23.7% of the cases, tumor is infiltrative 
which is slightly higher compared to similar study 
in Italy and lower compared to another study in 
Tanzania where they reported 20% and 26.6% 
respectively (10,11). Those with infiltrative type of 
HCC also have signs of advanced disease such as 
vascular invasion. Portal invasion was seen in 
55.7% of the cases. This is consistent with figures 
in literatures which state portal vein invasion in 44-
62.8% of the times. Portal and/or other vascular 
invasions were seen in 70% of the cases (12). 
Lymph node metastasis and distant metastasis 
reported in 21.4% and 24% respectively. The lung 
was the most frequent (53%) site of metastases. 
This result is in agreement with a study done in the 
University of Pittsburgh Medical Center where 
they found 55% of distant metastasis in the lung 
(13). Background liver cirrhosis is demonstrated in 
62.9% of the cases. Liver cirrhosis was found in a 
relatively higher (66.2%) of the cases in Indian 
study (11). 
  HBV and HCV markers were positive in 
21.4% and 7.1% of the cases respectively. Hepatitis 
B surface antigen (HBsAg) and Hepatitis C virus 
antibody (HCVab) results were negative in 
29(41%) participants, and the tests were not 
performed in 13 (19.1%) of the patients. In this 
study, relatively a comparable number of HBV 
infection and less number of HCV infection 
reported in a study undertaken in Ethiopia where 
both markers were positive in 24% of cases. Both 
HBV and HCV infections were less compared to 
the study in Tanzania where they found 65% and 
16.9% of cases positive for HBsAg and HCV 
antibody respectively (9,10). Risk factors 
assessment was difficult in this study due to 
incomplete laboratory workup and clinical data. 
More sensitive diagnostic tests such as HBV DNA 
and HCV RNA tests should be administered to 
detect occult hepatitis infections.  
In conclusion, the majority of the patients in 
this study had evidence of advanced disease such 
as vascular invasion and metastasis at the time of 
presentation. A significant number of the patients 
had negative results for major risk factors. Further 
investigation is recommended regarding the risk 
factors of HCC in our setting; introduction of 
surveillance program for high-risk groups can 




1. El-Serag HB. Epidemiology of Viral Hepatitis 
and Hepatocellular Carcinoma. 
Gastroenterology. 2012 2012/05/01/; 
142(6):1264-73. 
2. Blonski W, Kotlyar DS, Forde KA. Non-viral 
causes of hepatocellular carcinoma. World J 
Gastroenterol 2010; 16:3603-15. 
3. Abate Bane, Aravind Patil, and Mahafroz 
Khatib. Healthcare cost and access to care for 
viral hepatitis in Ethiopia, Expert survey 
findings 2014. International Journal of 
Innovation and Applied Studies ISSN 2028-
9324 Vol. 9 No. 4 Dec. 2014, pp. 1718-1723.  
4. Francesco Bellissimo, Diagnostic and 
therapeutic management of hepatocellular 
carcinoma, World J Gastroenterol 2015 
November 14; 21(42): 12003-12021.  
5. Marrero JA, Hussain HK, Nghiem HV, Umar 
R, Fontana RJ, Lok AS. Improving the 
prediction of hepatocellular carcinoma in 
cirrhotic patients with an arterially-enhancing 
liver mass. Liver Transpl 2005; 11: 281-289. 
           Ethiop J Health Sci.                               Vol. 30,  No. 2                               March 2020 
 
 





6. Leoni S, Piscaglia F, Golferi R, et al. The 
impact of vascular and nonvascular findings 
on the noninvasive diagnosis of small 
hepatocellular carcinoma based on the EASL 
and AASLD criteria. Am J Gastroenterol 
2010; 105: 599-609.   
7. Helena Nordenstedt, Donna L. White, and 
Hashem B. El-Serag, the changing pattern of 
epidemiology in hepatocellular carcinoma, 
Dig Liver Dis. 2010; 42(Suppl 3): S206–
S214.   
8. Yuan JM, Ross RK, Stanczyk FZ, et al. A 
cohort study of serum testosterone and 
hepatocellular carcinoma in Shanghai, China. 
Int J Cancer. 1995 Nov 15; 63(4):491–3. 
9. Hailemichael Desalegn, Suraj Sharma, Abate 
Shewaye, Jordan Feld, Endale Lulu, Major 
risk factors, clinical and laboratory 
characteristics of patients with hepatocellular 
carcinoma; a retrospective study at Tikur 
Anbassa Hospital, Addis Ababa University, 
Addis Ababa, Ethiopia, Ethiop Med J, 2015, 
Vol. 53, No.3. 
10. Hyasinta Jaka, Stephen E Mshana, Peter F 
Rambau, Nestory Masalu, Phillipo L Chalya 
and Samuel E Kalluvya, Hepatocellular 
carcinoma: clinicopathological profile and 
challenges of management in a resource-
limited setting, World Journal of Surgical 
Oncology 2014, 12:246. 
11. Benvegnù L, Noventa F, Bernardinello E, 
Pontisso P, Gatta A, Alberti A. Evidence for 
an association between the aetiology of 
cirrhosis and pattern of hepatocellular 
carcinoma development. Gut 2001; 
48(1):110–115. 
12. Samir Shah, Akash Shukla, Bhawan 
Paunipagar, Radiological Features of 
Hepatocellular Carcinoma, J CLIN EXP 
HEPATOL 2014; 4:S63–S66. 
13. Sanjeev Katyal, James H. Oliver III, Mark S. 
Peterson, James V. Ferris,  Brian S. Carr, 
Richard L. Baron, Extrahepatic Metastases of 
Hepatocellular Carcinoma, Radiology 2000; 
216:698–703. 
 
 
 
